An organobismuth compound that exhibits selective cytotoxicity to vascular endothelial cells in vitro

Journal of Health Science

Volumn 51, Issue 3, 2005, Pages 333-340

  Fujiwara, Yasuyuki ^a   Mitani, Makoto ^a   Yasuike, Shuji ^a   Kurita, Jyoji ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Antimony; Bismuth; Cytotoxicity; Vascular endothelial cell

Indexed keywords

(1 PHENYLETHYNYL) ALPHA NAPHTHYL 4 TOLYLSTIBANE; 1 [8 (N,N DIMETHYLAMINOMETHYL)NAPHTHYL]BIS(4 METHYLPHENYL)STIBANE; 1 PHENYL 1 BENZOSTIBOLE; 1 PHENYL 1 STIBAPHENALENE; 1 PHENYL 2 TRIMETHYLSILYL 1 BENZOSTIBOLE; 1 PHENYL 2 TRIMETHYLSILYL 1 BENZOSTILYL 1 BENZOBISMEPINE; 1 PHENYL 2 TRIMETHYLSILYL 1 BENZOSTILYL 1 BENZOSTIBEPINE; 1 PHENYL 2 TRIMETHYLSILYLTHIENO[2,3 B]STIBOLE; 1 PHENYLTHIENO[3,4 B]STIBOLE; 1,1 DIBROMO 1 PHENYL 1 BENZOSTIBOLE; 1,1 DICHLORO 1 PHENYL 1 BENZOSTIBOLE; 2 (2 METHYLSULFANYLETHYL)PHENYLBIS(4 METHYLPHENYL)STIBANE; 2 (METHOXYMETHYL)PHENYLBIS(4 METHYLPHENYL)STIBANE; 2 (METHYLSULFANYLMETHYL)PHENYLBIS(4 METHYLPHENYL)STIBANE; 2 (N,N DIMETHYLAMINOMETHYL)PHENYLBIS(4 METHYLPHENYL)BISMUTHANE; 2 (N,N DIMETHYLAMINOMETHYL)PHENYLBIS(4 METHYLPHENYL)STIBANE; 2,2' BIS[DI (4 TOLYL)STIBANO] 1,1' BINAPHTHYL; 5 PHENYLDIBENZO[B,F]STIBEPINE; 8 PHENYLDIBENZO[B,I] 1 OXA 6 STIBOCINE; 9,10 DIHYDRO 9 PHENYL 9 STIBANTHRACENE; ANTIMONY DERIVATIVE; BIS(1 PHENYLETHYNYL) 4 TOLYLSTIBANE; BISMUTH DERIVATIVE; LACTATE DEHYDROGENASE; ORGANOBISMUTH DERIVATIVE; TRIPHENYLBISMUTHANE; TRIPHENYLSTIBANE; TRIS(4 FLUOROPHENYL)STIBANE; TRIS(4 METHOXYPHENYL)STIBANE; TRIS(4 METHYLPHENYL)BISMUTHANE; TRIS(4 METHYLPHENYL)STIBANE; TRIS[2 (METHOXYMETHYL)PHENYL]BISMUTHANE; TRIS[2 (METHOXYMETHYL)PHENYL]STIBANE; TRIS[2 (METHYLSULFANYLMETHYL)PHENYL]BISMUTHANE; TRIS[2 (METHYLSULFANYLMETHYL)PHENYL]STIBANE; TRIS[2 (N,N DIMETHYLAMINOMETHYL)PHENYL]BISMUTHANE; TRIS[2 (N,N DIMETHYLAMINOMETHYL)PHENYL]STIBANE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; AORTA MEDIA; ARTICLE; CANCER THERAPY; CELL MEMBRANE PERMEABILITY; CELL STRAIN; CELL STRAIN IMR 90; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SELECTIVITY; ENDOTHELIUM CELL; FETUS; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY EPITHELIUM; LUNG FIBROBLAST; NONHUMAN; SMOOTH MUSCLE FIBER; STRUCTURE ACTIVITY RELATION; VASCULAR ENDOTHELIUM;

ANIMALIA; BOVINAE; SUIDAE;

EID: 21144438601     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.51.333     Document Type: Article

References (35)

1. Munro, J. M. and Cotran, R. S. (1988) The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab. Invest., 58, 249-261.
2. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London), 362, 801-809.
3. Desoize, B. (2004) Metals and metal compounds in cancer treatment. Anticancer Res., 24, 1529-1544.
4. Müller, S., Miller, W. H., Jr. and Dejean, A. (1998) Trivalent antimonials induce degradation of the PML-RARα oncoprotein and reorganization of the promyelocytic leukemia nuclear bodies in acute promyelocytic leukemia NB4 cells. Blood, 92, 4308-4316.
5. 2O (dtpa=diethylenetriamine-pentaacetic acid). Main Group Metal Chem., 20, 169-180.
6. Steinbach, G., Ford, R., Glober, G., Sample, D., Hagemeister, F. B., Lynch, P. M., McLaughlin, P. W., Rodriguez, M. A., Romaguera, J. E., Sarris, A. H., Younes, A., Luthra, R., Manning, J. T., Johnson, C. M., Lahoti, S., Shen, Y., Lee, J. E., Winn, R. J., Genta, R. M., Graham, D. Y. and Cabanillas, F. F. (1999) Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann. Intern. Med., 131, 88-95.
7. Kondo, Y., Satoh, M., Imura, N. and Akimoto, M. (1992) Tissue-specific induction of metallothionein by bismuth as a promising protocol for chemotherapy with repeated administration of cis-diamminedichloroplatinum (II) against bladder tumor. Anticancer Res., 12, 2303-2307.
8. Wada, M., Natsume, S., Suzuki, S., Uo, A., Nakamura, M., Hayase, S. and Erabi, T. (1997) Two-step synthesis of triarylmetals (As, Sb, Bi) starting from the metal oxides and 2,6-dimethoxybenzenethiol. J. Organomet. Chem., 656, 234-242.
9. Talalaeva, T. V. and Kocheshkov, K. A. (1946) Synthesis of antimony organic compounds by lithium organic compounds. J. Gen. Chem. (U.S.S.R.), 16, 777-780.
10. Forster, G. E., Begley, M. J. and Sowerby, D. B. (1996) Tri- and di-arylantimony(V) thiocyanates and mixed halide thiocyanates; crystal structure of triphenylantimony(V) di-isothiocyanate. J. Organomet. Chem., 507, 263-274.
11. Kamepalli, S., Carmalt, C. J., Culp, R. D., Cowley, A. H., Jones, R. A. and Norman, N. C. (1996) Synthesis and structures of intramolecularly base-coordinated aryl Group 15 compounds. Inorg. Chem., 35, 6179-6183.
12. Bickelhaupt, F., Lourens, R., Vermeer, H. and Weustink, R. J. M. (1979) Attempted syntheses of 9-stibaanthracene and 10-phenyl-9-stibaanthracene. Recl. Trav. Chim. Pays-Bas., 98, 3-4.
13. Tokunaga, T., Seki, H., Yasuike, S., Ikoma, M., Kurita, J. and Yamaguchi, K. (2000) Confirmation and characterization of the hypervalent Sb⋯N bonding recognized in triarylstibanes bearing an amino side chain by X-ray, NMR and theoretical calculations. Tetrahedron, 56, 8833-8839.
14. Okajima, S., Yasuike, S., Kakusawa, N., Osada, A., Yamaguchi, K., Seki, H. and Kurita, J. (2002) Synthesis of Sb-chiral organoantimony compounds having intramolecular Sb-N interaction and their separation into optically pure compounds via orthopalladated benzylamine complexes. J. Organomet. Chem., 656, 234-242.
15. Yasuike, S., Okajima, S., Yamaguchi, K., Seki, H. and Kurita, J. (2003) New optically active organoantimony (BINASb) and bismuth (BINABi) compounds comprising a 1,1′-binaphthyl core: synthesis and their use in transition metal-catalyzed asymmetric hydrosilylation of ketones. Tetrahedron, 59, 4961-4968.
16. Yasuike, S., Iida, T., Okajima, S., Yamaguchi, K., Seki, H. and Kurita, J. (2001) Synthesis, molecular structure and fluxional behavior of (R)-7-p-tolyldinaphtho[2,1-b;1′,2′-if|stibole: the first isolated example of optically active group 15 dinaphthoheteroles. Tetrahedron Lett., 42, 441-444.
17. Kurita, J., Ishii, M., Yasuike, S. and Tsuchiya, T. (1994) Synthesis of 1-benzometalloles containing group 14, 15, and 16 heavier elements via a common dilithiostyrene intermediate. Chem. Pharm. Bull., 42, 1437-1441.
18. Yasuike, S., Kurita, J. and Tsuchiya, T. (1997) Syntheses of novel group 15 and 16 thieno[2,3-b]-, thieno[3,4-b]-, and thieno[3,2-b]heteroles. Heterocycles, 45, 1891-1894.
19. Yasuike, S., Ohta, H., Shiratori, S., Kurita, J. and Tsuchiya, T. (1993) Syntheses of the group 15 1-benzoheteroepines, dibenzo[b,d]heteroepines and dibenzo[b,f]heteroepines involving the first isolated examples of arsepines and bismepines. J. Chem. Soc. Chem. Commun., 1817-1819.
20. Yasuike, S., Niwa, M., Yamaguchi, K., Tsuchiya, T. and Kurita, J. (2001) Synthesis of 1-stibaphenalenes, the first example of group 15 phenalenes, via a 1,5-dilithium intermediate. Chem. Lett., 554-555.
21. Yasuike, S., Tsukada, S., Kurita, J., Tsuchiya, T., Tsuda, Y., Kiuchi, H. and Hosoi, S. (2000) Synthesis and structure of novel dibenzo[b,i]-1-oxa-6- heteroecines containing group 15 heavier elements. Heterocycles, 53, 525-528.
22. 1 cells. Toxicol. Lett., 89, 131-137.
23. Schuger, L., Varani, J., Marks, R. M., Kunkel, S. L., Johnson, K. J. and Ward, P. A. (1989) Cytotoxicity of tumor necrosis factor-α for human umbilical vein endothelial cells. Lab. Invest., 61, 62-68.
24. Sato, N., Goto, T., Haranaka, K., Satomi, N., Nariuchi, H., Mano-Hirano, Y. and Sawasaki, Y. (1986) Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity. J. Natl. Cancer Inst., 76, 1113-1121.
25. Pohlman, T. H. and Harlan, J. M. (1989) Human endothelial cell response to lipopolysaccharide, interleukin-1, and tumor necrosis factor is regulated by protein synthesis. Cell. Immunol., 119, 41-52.
26. Shen, Y. H., Wang, X. L. and Wilcken, D. E. (1998) Nitric oxide induces and inhibits apoptosis through different pathways. FEBS Lett., 433, 125-131.
27. Yamaoka, J., Kabashima, K., Kawanishi, M., Toda, K. and Miyachi, Y. (2002) Cytotoxicity of IFN-γ and TNF-α for vascular endothelial cell is mediated by nitric oxide. Biochem. Biophys. Res. Commun., 291, 780-786.
28. Chandra, D., Ramana, K. V., Friedrich., B., Srivastava, S., Bhatnagar, A. and Srivastava, S. K. (2003) Role of aldose reductase in TNF-α-induced apoptosis of vascular endothelial cells. Chem. Biol. Interact., 143-144, 605-612.
29. Denekamp, J. (1993) Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol., 66, 181-196.
30. Webb, M. (1975) The metallothioneins. Biochem. Soc. Trans., 3, 632-634.
31. Brady, F. O. and Webb, M. (1981) Metabolism of zinc and copper in the neonate. (Zinc, copper)-thionein in the developing rat kidney and testis. J. Biol. Chem., 256, 3931-3935.
32. Thornalley, P. J. and Vasak, M. (1985) Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim. Biophys. Acta, 827, 36-44.
33. Kaji, T., Yamamoto, C., Tsubaki, S., Ohkawara, S., Sakamoto, M., Sato, M. and Kozuka, H. (1993) Metallothionein induction by cadmium, cytokines, thrombin and endothelin-1 in cultured vascular endothelial cells. Life Sci., 53, 1185-1191.
34. Kaji, T., Yamamoto, C., Suzuki, M., Miyajima, S., Fujiwara, Y., Sakamoto, M. and Koizumi, F. (1995) Induction of metallothionein by thrombin in cultured vascular endothelial and smooth muscle cells. Biol. Pharm. Bull., 18, 1272-1274.
35. Kaji, T., Suzuki, M., Yamamoto, C., Imaki, Y., Mishima, A., Fujiwara, Y., Sakamoto, M. and Kozuka, H. (1994) Induction of metallothionein synthesis by bismuth in cultured vascular endothelial cells. Res. Commun. Mol. Pathol. Pharmacol., 86, 25-35.